510 related articles for article (PubMed ID: 9468140)
1. Retinoblastoma protein represses transcription by recruiting a histone deacetylase.
Magnaghi-Jaulin L; Groisman R; Naguibneva I; Robin P; Lorain S; Le Villain JP; Troalen F; Trouche D; Harel-Bellan A
Nature; 1998 Feb; 391(6667):601-5. PubMed ID: 9468140
[TBL] [Abstract][Full Text] [Related]
2. Retinoblastoma protein recruits histone deacetylase to repress transcription.
Brehm A; Miska EA; McCance DJ; Reid JL; Bannister AJ; Kouzarides T
Nature; 1998 Feb; 391(6667):597-601. PubMed ID: 9468139
[TBL] [Abstract][Full Text] [Related]
3. [Histone deacetylase and retinoblastoma protein].
Magnaghi-Jaulin L; Groisman R; Naguibneva I; Robin P; Trouche D; Harel-Bellan A
Bull Cancer; 1998 Jul; 85(7):606-7. PubMed ID: 9752266
[TBL] [Abstract][Full Text] [Related]
4. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.
Robertson KD; Ait-Si-Ali S; Yokochi T; Wade PA; Jones PL; Wolffe AP
Nat Genet; 2000 Jul; 25(3):338-42. PubMed ID: 10888886
[TBL] [Abstract][Full Text] [Related]
5. The Rb/chromatin connection and epigenetic control: opinion.
Ferreira R; Naguibneva I; Pritchard LL; Ait-Si-Ali S; Harel-Bellan A
Oncogene; 2001 May; 20(24):3128-33. PubMed ID: 11420729
[TBL] [Abstract][Full Text] [Related]
6. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
7. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter.
Stiegler P; De Luca A; Bagella L; Giordano A
Cancer Res; 1998 Nov; 58(22):5049-52. PubMed ID: 9823308
[TBL] [Abstract][Full Text] [Related]
8. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of active transcriptional repression by the retinoblastoma protein.
Weintraub SJ; Chow KN; Luo RX; Zhang SH; He S; Dean DC
Nature; 1995 Jun; 375(6534):812-5. PubMed ID: 7596417
[TBL] [Abstract][Full Text] [Related]
10. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase.
Ferreira R; Magnaghi-Jaulin L; Robin P; Harel-Bellan A; Trouche D
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10493-8. PubMed ID: 9724731
[TBL] [Abstract][Full Text] [Related]
11. Regulation of E2F1 activity by acetylation.
Martínez-Balbás MA; Bauer UM; Nielsen SJ; Brehm A; Kouzarides T
EMBO J; 2000 Feb; 19(4):662-71. PubMed ID: 10675335
[TBL] [Abstract][Full Text] [Related]
12. Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product.
Zacksenhaus E; Jiang Z; Phillips RA; Gallie BL
EMBO J; 1996 Nov; 15(21):5917-27. PubMed ID: 8918469
[TBL] [Abstract][Full Text] [Related]
13. RbAp48 belongs to the histone deacetylase complex that associates with the retinoblastoma protein.
Nicolas E; Morales V; Magnaghi-Jaulin L; Harel-Bellan A; Richard-Foy H; Trouche D
J Biol Chem; 2000 Mar; 275(13):9797-804. PubMed ID: 10734134
[TBL] [Abstract][Full Text] [Related]
14. Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation.
Xia X; Cheng A; Lessor T; Zhang Y; Hamburger AW
J Cell Physiol; 2001 May; 187(2):209-17. PubMed ID: 11268000
[TBL] [Abstract][Full Text] [Related]
15. Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression.
Wang S; Fusaro G; Padmanabhan J; Chellappan SP
Oncogene; 2002 Dec; 21(55):8388-96. PubMed ID: 12466959
[TBL] [Abstract][Full Text] [Related]
16. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
Darbinian N; Gallia GL; Kundu M; Shcherbik N; Tretiakova A; Giordano A; Khalili K
Oncogene; 1999 Nov; 18(46):6398-402. PubMed ID: 10597240
[TBL] [Abstract][Full Text] [Related]
17. Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH.
Pearson A; Greenblatt J
Oncogene; 1997 Nov; 15(22):2643-58. PubMed ID: 9400991
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional repression. The cancer-chromatin connection.
DePinho RA
Nature; 1998 Feb; 391(6667):533, 535-6. PubMed ID: 9468130
[No Abstract] [Full Text] [Related]
19. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
Hiyama H; Iavarone A; Reeves SA
Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
[TBL] [Abstract][Full Text] [Related]
20. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.
Wang S; Nath N; Adlam M; Chellappan S
Oncogene; 1999 Jun; 18(23):3501-10. PubMed ID: 10376528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
